Oracle Investment Management as of Dec. 31, 2016
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 17 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 27.8 | $168M | 1.2M | 134.48 | |
| Accelr8 Technology Corporation | 17.3 | $104M | 5.0M | 20.75 | |
| NxStage Medical | 11.8 | $71M | 2.7M | 26.21 | |
| Mazor Robotics Ltd. equities | 9.9 | $60M | 2.7M | 21.92 | |
| Quidel Corporation | 8.9 | $54M | 2.5M | 21.42 | |
| Opko Health (OPK) | 5.5 | $33M | 3.5M | 9.30 | |
| Amarin Corporation (AMRN) | 4.0 | $24M | 7.9M | 3.08 | |
| Pacific Biosciences of California (PACB) | 3.5 | $21M | 5.5M | 3.80 | |
| Biolase Technology | 3.4 | $21M | 15M | 1.40 | |
| Intrexon | 3.3 | $20M | 821k | 24.30 | |
| Vermillion | 1.4 | $8.2M | 8.6M | 0.95 | |
| shares Agenus | 1.3 | $7.9M | 1.9M | 4.12 | |
| Accuray Incorporated (ARAY) | 1.1 | $6.9M | 1.5M | 4.60 | |
| Contrafect | 0.3 | $2.1M | 1.2M | 1.75 | |
| Biogen Idec (BIIB) | 0.3 | $1.9M | 6.7k | 283.65 | |
| Second Sight Med Prods | 0.0 | $100k | 51k | 1.97 | |
| ZIOPHARM Oncology | 0.0 | $36k | 6.7k | 5.40 |
